thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
akynzeo 300 mg / 0.5 mg
orifarm as - netupitant / palonosetron - kapsel, hard - 300 mg / 0.5 mg
ismo retard 40 mg
2care4 - isosorbidmononitrat - depottablett - 40 mg
trica 20 mg/ ml
esteve pharmaceuticals gmbh - triamcinolonheksacetonid - injeksjonsvæske, suspensjon - 20 mg/ ml
britaject 5 mg/ ml
stada arzneimittel ag - apomorfinhydrokloridhemihydrat - infusjonsvæske, oppløsning i ferdigfylt sprøyte - 5 mg/ ml
nycoplus vitamin d3 800 ie
stada arzneimittel ag - kolekalsiferol - kapsel, myk - 800 ie
hypericum stada -
stada arzneimittel ag - prikkperikum - kapsel, hard
fultium 800 iu
stada arzneimittel ag - kolekalsiferol - kapsel, myk - 800 iu
bortezomib stada 2.5 mg/ ml
stada arzneimittel ag - bortezomibmannitolboronat - injeksjonsvæske, oppløsning - 2.5 mg/ ml